91AV

John Streicher, Ph.D., assistant professor of biomedical sciences, presented research from 91AV’s drug discovery and screening program at the Academic Screening Workshop 2013, which occurred September 17-18 in Baltimore, Maryland.

The poster presentation, titled “Drug Discovery at the 91AV: Identifying New Drugs for the Treatment of Chronic Pain,” showcased research from the drug discovery pipeline that is being developed at 91AV. 

Under the leadership of the Office of Research and Scholarship, headed by Vice-President for Research and Director of the Center for Excellence in the Neurosciences Ed Bilsky, Ph.D., and by the Center of Biomedical Research and Excellence (COBRE) program, headed by Ian Meng, Ph.D., professor in the Department of Biomedical Sciences,  this pipeline is being developed to discover new drugs for the treatment of chronic pain and other diseases from the earliest chemistry to final clinical testing in human patients.

The research highlighted at this conference includes medicinal chemistry from Cassia Mizuno, Ph.D., assistant professor in the College of Pharmacy; in vitro drug screening from Streicher and his In Vitro Drug Discovery Core; in vivo behavioral testing from Bilsky and the COBRE Behavioral Core; and pharmacokinetics/drug metabolism work from Karen Houseknecht, Ph.D., professor in the College of Pharmacy.

The presentation, therefore, demonstrated 91AV’s drug discovery capabilities and the progress of several drug discovery projects that seek to discover new drugs for chronic pain. The presentation also showcased 91AV’s capabilities for potential academic or industrial researchers who are interested in collaboration or contract research work.

Read more about research core facilities at 91AV, including the drug discovery core and the behavioral core.